These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22162643)

  • 1. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines.
    Stengel G; Bee EK
    Clin Interv Aging; 2011; 6():281-4. PubMed ID: 22162643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A injection for the treatment of frown lines.
    Song KH
    Ann Pharmacother; 1998 Dec; 32(12):1365-7. PubMed ID: 9876820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy.
    Lee SK
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S105-10. PubMed ID: 17278332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
    Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE; Easthope SE
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A; Carruthers J
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep resting glabellar rhytides respond to BTX-A and Hylan B.
    Carruthers J; Carruthers A; Maberley D
    Dermatol Surg; 2003 May; 29(5):539-44. PubMed ID: 12752525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique.
    Lowe NJ; Maxwell A; Harper H
    J Am Acad Dermatol; 1996 Oct; 35(4):569-72. PubMed ID: 8859286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.
    Berweck S; Schroeder AS; Lee SH; Bigalke H; Heinen F
    Dev Med Child Neurol; 2007 Jan; 49(1):62-4. PubMed ID: 17209979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.